Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.

Fiona Blackhall, Dong-Wan Kim, Benjamin Besse, Hiroshi Nokihara, Ji-Youn Han, Keith D Wilner, Arlene Reisman, Shrividya Iyer, Vera Hirsh, Alice T Shaw

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science